| Literature DB >> 31132473 |
Davide Mangioni1, Giacomo Grasselli2, Chiara Abbruzzese3, Antonio Muscatello4, Andrea Gori5, Alessandra Bandera5.
Abstract
Varicella zoster virus (VZV) pneumonia is associated with significant mortality, especially in the immunocompromised host. VZV-specific immunoglobulins (VZIG) are currently used as post-exposure prophylaxis for at-risk patients, but not as adjunctive therapy. A novel case of VZV pneumonia in an immunocompromised patient, treated successfully with intravenous VZIG in combination with acyclovir, is reported here.Entities:
Keywords: Immunocompromised host; Intensive care unit; Intravenous immunoglobulins; Pneumonia; Varicella zoster virus
Mesh：
Substances：
Year: 2019 PMID： 31132473 DOI： 10.1016/j.ijid.2019.05.022
Source DB: PubMed Journal: Int J Infect Dis ISSN： 1201-9712 Impact factor: 3.623